Skip to content Skip to Search
Skip navigation

Saudi pharma firm to buy manufacturing site in Algeria

Jamjoon Pharmaceuticals raised $336 million in an initial public offering earlier this year Unsplash/Volodymyr Hryshchenko
Jamjoon Pharmaceuticals raised $336 million in an initial public offering earlier this year
  • Jamjoon increases investment in joint venture
  • Plant in Algiers produces tablets, capsules and powders
  • Saudi pharma industry worth $11.7bn

Jamjoom Pharmaceuticals Factory Company has increased capital in its joint venture in Algeria to help finance the acquisition of a manufacturing facility.

In a filing to the Saudi Stock Exchange, the company, which raised $336 million in an initial public offering in May, announced the additional funding in Jamjoom Algeria Lil Dawa, in which it owns 49 percent. 

The tie-up with Dawa Investment will create and issue 2.2 million new shares, with the capital increasing to $17.3 million.

The latest cash injection will partially fund the purchase of a site in Algiers, with an initial payment of $14 million. 

It will also finance the day-to-day factory operations, Jamjoon said in the filing, adding that it has invested $8 million with the remainder financed by a Shariah-compliant banking facility agreement between the joint venture and a bank in Algeria.

The factory produces a range of tablets, capsules and powders and is expected to begin operations immediately with the company seeing a financial impact from Q3 onwards.

Earlier this month, Jamjoom reported net profit of $22.5 million for the first quarter of 2023, up 94 percent compared to the previous year. 

The company generated revenue of $80.5 million in Q1, an increase of 24 percent on the back of strong demand for its products.

In May, Jamjoom’s IPO secured two cornerstone investors – Saudi Economic and Development Holding Co and Al Faisaliah Group – who subscribed for almost a quarter of the offering. 

The business develops, manufactures and markets a range of branded pharmaceutical products, with its main facility in Jeddah delivering 113 million units per year.

Analysts at BMI, formerly Fitch Solutions, expect pharmaceutical investment in Saudi Arabia to grow strongly, describing the market as an “attractive business landscape”.

The Saudi pharmaceutical industry was valued at $11.7 billion last year, according to BMI, and is estimated to grow annually at over 5 percent to $15.1 billion in 2027 and $19.8 billion in 2032. 

Latest articles

Saudi Data and Artificial Intelligence Authority (SDAIA) director Dr Esam bin Abdullah Al-Wagait

IBM to help Saudi Arabia train AI models in Arabic

Saudi Arabia has signed a deal with US tech giant IBM to develop the kingdom’s generative artificial intelligence (AI) capabilities. The Saudi Data and Artificial Intelligence Authority (SDAIA) said on Tuesday that its Arabic language AI model, ALLaM, will be trained on IBM’s platform to run more efficiently. This will also add new language skills […]

Marina Storti, CEO of WTA Ventures, front right, and Kevin Foster, head of communications at PIF, front left, at the signing of the sponsorship agreement between the two

PIF to sponsor women’s world tennis rankings

Saudi Arabia’s Public Investment Fund (PIF) is giving its name to the women’s world tennis rankings, the latest sponsorship deal in the kingdom’s drive to dominate global sports.  “The PIF WTA Rankings will track players’ journeys, and PIF will work with the WTA to celebrate and support players’ progress,” PIF said, calling the deal “multi-year”.  […]

Adnoc’s investment in Mozambique aligns with its expansion strategy for a lower-carbon LNG portfolio

Adnoc buys 10% in LNG project in Mozambique

Abu Dhabi National Oil Company (Adnoc) has acquired a 10 percent stake from Portugal’s Galp Energia in the Rovuma basin concession in Mozambique as part of its global growth strategy.  The acquisition will allow the UAE energy major a share of the liquefied natural gas (LNG) production from the concession, which has a combined production capacity […]

An orange vendor in Cairo. The country will export 2 million tonnes of oranges this year

Egyptian agricultural exports hit record levels

Egypt exported a record 7.5 million tonnes of agricultural produce last year, compared with 6.4 million tonnes in 2022 and 5.6 million in 2021. The total value of agricultural exports in 2023 was $8.8 billion, according to minister of agriculture and land reclamation Al Sayed Al Quseir. Egypt’s total number of export partners has increased […]